Clinical Study
Vinpocetine and Pyritinol: A New Model for Blood Rheological Modulation in Cerebrovascular Disorders—A Randomized Controlled Clinical Study
Table 3
Dual combined effects of vinpocetine and pyritinol on hemorheological parameters in cerebrovascular disorders.
| Variables | Before | After | value |
| Hematocrit % | 45.7 ± 0.23 | 43.1 ± 0.65 | | Total serum protein g/dl | 8.64 ± 0.21 | 8.12 ± 2.76 | | Fibrinogen g/l | 3.78 ± 0.87 | 1.99 ± 0.09 | | Relative blood viscosity cP | 4.33 ± 0.65 | 1.98 ± 0.02 | | Actual blood viscosity cP | 3.3685 ± 0.021 | 1.0185 ± 0.45 | | WBV-HSR cP | 6.6009 ± 0.032 | 5.172 ± 0.026 | | WBV-LSR cP | 116.377 ± 0.165 | 81.45918 ± 2.23 | | RRI | 2.17 ± 0.011 | 1.75 ± 0.03 | | Plasma viscosity cP | 1.55 ± 0.06 | 0.58 ± 0.006 | | Kinematic viscosity | 3.18 ± 0.17 | 0.960 ± 0.002 | |
|
|
WBV-HSR: whole blood viscosity high shear rate, WBV-LSR: whole blood viscosity low shear rate, and RRI: RBC rigidity index.
|